Ryan Morris
Psychiatric/Mental Health · New York, NYNPI 1558746362
Payments from drug & device makers
Across 126 payments — averaging $72.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$6K
- E.r. Squibb & Sons, L.L.C.$647
- Teva Pharmaceuticals USA, Inc.$602
- Neurocrine Biosciences, Inc.$486
- Alkermes, Inc.$354
- Vanda Pharmaceuticals Inc.$307
- plus $963 from 9 others
What the payments were for
- Speaking & faculty fees$5,50060%
- Food & beverage$3,48738%
- Education$1091%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 24 | $5,738 |
| E.r. Squibb & Sons, L.L.C. | 7 | $647 |
| Teva Pharmaceuticals USA, Inc. | 5 | $602 |
| Neurocrine Biosciences, Inc. | 32 | $486 |
| Alkermes, Inc. | 9 | $354 |
| Vanda Pharmaceuticals Inc. | 11 | $307 |
| Johnson & Johnson | 3 | $274 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $161 |
| Sunovion Pharmaceuticals Inc. | 7 | $120 |
| Eisai Inc. | 6 | $110 |
| Lundbeck LLC | 4 | $81 |
| Otsuka America Pharmaceutical, Inc. | 4 | $75 |
| Avanir Pharmaceuticals, Inc. | 5 | $74 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $53 |
| Jazz Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$5,500
- COBENFY$553
- LYBALVI$470
- UZEDY$372
- INGREZZA$241
- INVEGA SUSTENNA$241
- Austedo XR$120
How this compares
$9,096 in reported general payments places this provider in the 95th percentile of 2,385 psychiatric/mental health providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 32 | $1,012 |
| Escitalopram Oxalate | 91 | $487 |
| Duloxetine Hcl | 24 | $385 |
| Quetiapine Fumarate | 38 | $374 |
| Mirtazapine | 34 | $251 |
| Buspirone Hcl | 26 | $211 |
| Clonazepam | 115 | $200 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 11 | $146 |
| Prazosin Hcl | 15 | $122 |
| Trazodone Hcl | 35 | $121 |
| Citalopram HbrCitalopram Hydrobromide | 13 | $115 |
| Lorazepam | 21 | $100 |
| Sertraline Hcl | 30 | $69 |
| Zolpidem Tartrate | 39 | $67 |
| Gabapentin | 16 | $53 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in New York
- Mary OlsonNew York$142K
- Richard CalladoNew York$47K
- Darcy LeonNew York$37K
- Angela AnukamNew York$11K
- Glenn HannDansville$1.3M
- Tammy RussoNiskayuna$568K
- Carrie EdickSchenectady$484K
- Eric SpronzCentereach$448K
- Terry Jo Brooks-DevlinTonawanda$176K
- Kevin SiewersStaten Island$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.